Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Kedudukan dalam Saham #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Harga Saham
$0.617
Disegerakkan terakhir: 2024-10-14
Modal Pasaran
$6.13M
Perubahan (1 hari)
0.49%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Kineta, Inc. (KA)

Kategori

EPS untuk Kineta, Inc. (KA)
EPS setakat March 2025 TTM: $-0.66
Menurut laporan kewangan terkini dan harga saham Kineta, Inc., EPS semasa syarikat (TTM) adalah $-0.66. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-1.28 penurunan berbanding EPS tahun 2022 iaitu $-12.80.
Sejarah EPS untuk Kineta, Inc. dari 2015 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-0.66 -53.52%
2024 $-1.42 10.94%
2023 $-1.28 -90.00%
2022 $-12.80 57.25%
2021 $-8.14 -80.27%
2020 $-41.26 -74.51%
2019 $-161.86 -28.02%
2018 $-224.87 -31.33%
2017 $-327.48 17.86%
2016 $-277.86 97.27%
2015 $-140.85 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -2,724.24%
US
$27.74 -4,303.03%
NL
- -
CH
- -
KR
$13.70 -2,175.77%
BE